Methods: Patients scheduled to undergo transurethral resection of the prostate were randomized to receive either 8 mg isobaric levobupivacaine 0.5% with 3 mcg sufentanil (group L) or 8 mg of isobaric bupivacaine 0.5% with 3 mcg sufentanil (group B) for spinal anaesthesia.